Genomma Lab reports Q2 2026 net sales down 6%, net income up 5.5%

The Mexican consumer health company said gross margin widened to 64.6% and EBITDA margin fell to 21.8% as productivity gains offset higher promotional spending and a new Mexico beverage tax.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.